|
|
|
41
|
64212
|
NEORAL 100MG/ML SOLN (NVS) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50ML
|
BQ
|
475.71
|
475.7067
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
64212
|
NEORAL 100MG/ML SOLN (NVS) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50ML
|
BQ
|
475.71
|
475.71
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
64225
|
NEORAL 25MG TAB (NVS/COL) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
135.18
|
2.70
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
64225
|
NEORAL 25MG TAB (NVS) CYCLOSPORIN (BQ)
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
135.18
|
2.7036
|
TAB
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
64225
|
NEORAL 25MG TAB (NVS) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
135.18
|
2.70
|
TAB
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
6422B
|
NEORAL 100MG TAB (NVS/COL) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
529.88
|
10.60
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
6422B
|
NEORAL 100MG TAB (NVS) CYCLOSPORIN (BQ)
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
529.88
|
10.5977
|
TAB
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
6422B
|
NEORAL 100MG TAB (NVS) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50'S
|
BQ
|
529.88
|
10.60
|
TAB
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
64231
|
RESTASIS 0.05% EYE (ALL/COL) CYCLOSPORIN
|
CYCLOSPORIN
|
RESTASIS
|
30X0.4ML
|
C
|
67.96
|
2.27
|
EYE DROP
|
0
|
AMP
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
64231
|
RESTASIS 0.05% EYE DR (ALL) CYCLOSP (C)
|
CYCLOSPORIN
|
RESTASIS
|
30X0.4ML
|
C
|
67.96
|
2.2653
|
AMPP
|
0
|
BOX
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
64231
|
RESTASIS 0.05% EYE DR (ALL) CYCLOSPORIN
|
CYCLOSPORIN
|
RESTASIS
|
30X0.4ML
|
C
|
67.96
|
2.27
|
AMPP
|
0
|
BOX
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
AVENTA BARBADOS
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
41
|
64235
|
CLOSPORIL 0.1% EYE DR (LPO) CYCLOSPORIN (C)
|
CYCLOSPORIN
|
CLOSPORIL
|
5ML
|
C
|
10.06
|
10.0578
|
BOTT
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
64235
|
CLOSPORIL 0.1% EYE DR (LPO) CYCLOSPORIN
|
CYCLOSPORIN
|
CLOSPORIL
|
5ML
|
C
|
16.31
|
16.31
|
BOTT
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
41
|
6432D
|
FOLINIC ACID 50MG INJ (ZUV) CALCIUM FOLI (BQ)
|
CALCIUM FOLINATE
|
FOLINIC ACID
|
50MG VIAL
|
BQ
|
5.57
|
5.5726
|
VIAL
|
0
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9212
|
ANTIDOTES
|
2024-04-01
|
2026-03-31
|
|
INJ
|
0
|
ANTIDOTES
|
|
|
|
|
42
|
6432D
|
FOLINIC ACID 50MG INJ (ZUV) CALCIUM FOLI
|
CALCIUM FOLINATE
|
FOLINIC ACID
|
50MG VIAL
|
BQ
|
4.65
|
4.65
|
VIAL
|
0
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9212
|
ANTIDOTES
|
2026-04-01
|
|
|
INJ
|
0
|
ANTIDOTES
|
|
|
|
|
40
|
6432G
|
LEUCOVORIN 50MG INJ (SLS/AHI)
|
LEUCOVORIN
|
LEUCOVORIN
|
10ML VIAL
|
BQ
|
22.29
|
22.29
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9212
|
ANTIDOTES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
6432H
|
LEUCOVORIN 50MG INJ (SLS/AHI)
|
LEUCOVORIN
|
LEUCOVORIN
|
5ML
|
BQ
|
12.45
|
12.45
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9212
|
ANTIDOTES
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-03-29
|
|
|
|
42
|
64356
|
FOLINIC ACID 15MG TAB (ZUV)
|
FOLINIC ACID
|
FOLINIC ACID
|
10'S
|
BQ
|
16.80
|
1.68
|
TAB
|
0
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9212
|
ANTIDOTES
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIDOTES
|
|
|
|
|
40
|
64358
|
LEUCOVORIN 15MG TAB (SLS/AHI)
|
LEUCOVORIN
|
LEUCOVORIN
|
20'S
|
BQ
|
95.28
|
4.76
|
TABLET
|
0
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9212
|
ANTIDOTES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
64358
|
LEUCOVORIN 15MG TAB (SLS)
|
LEUCOVORIN
|
LEUCOVORIN
|
20'S
|
BQ
|
97.89
|
4.8943
|
TAB
|
0
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9212
|
ANTIDOTES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTIDOTES
|
|
